GeneSight is a pharmacogenomic test that analyzes clinically important genetic variations that may affect your response to medications. The results of the test can provide the medical team at Ahwatukee Health Care information about which medications may be more likely to work for you. It can also identify medications that may require dose adjustments or have an increased risk of side effects based on your genetic makeup.
The GeneSight Psychotropic Test
The GeneSight Psychotropic test analyzes how your genes may affect your outcomes with medications commonly prescribed to treat depression, anxiety, ADHD, and other mental health conditions. The GeneSight Psychotropic test provides Ahwatukee Health Care with information about which medications may require dose adjustments, may be less likely to work for you or may have an increased risk of side effects based on your genetic makeup.
GeneSight Psychotropic Clinical Studies
There are seven published peer-reviewed studies showing the clinical validity, clinical utility, and economic utility of the GeneSight Psychotropic test. In the GUIDED study, when clinicians used the GeneSight Psychotropic test to guide treatment decisions, patients saw a 50% improvement in remission rates versus treatment as usual. You can
learn more about the clinical evidence supporting the use of the GeneSight Psychotropic test at www.genesight.com/for-clinicians.
Cost of the GeneSight Test
Many commercial and government insurance plans reimburse for all or part of the cost of the GeneSight test. For patients with commercial insurance, there is also an opportunity to apply for the GeneSight Financial Assistance Program. Let your medical team at Ahwatukee Health Care know that you would like more information on these options during your next appointment!